Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Judge 

Hologic Inc. diskutieren

Hologic Inc.

WKN: 879100 / Symbol: HOLX / Name: Hologic / Aktie / Ausrüstung & Versorgung / Large Cap /

69,00 €
-0,71 %

Sell Hologic Inc.

Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,20 %
Kursziel 84,60
Veränderung
Endet am 14.07.24

Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $95.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,29 %
Kursziel 86,57
Veränderung
Endet am 01.08.24

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $95.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,29 %
Kursziel 86,57
Veränderung
Endet am 01.08.24

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $95.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,29 %
Kursziel 86,57
Veränderung
Endet am 01.08.24

Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Raymond James from $100.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,29 %
Kursziel 80,49
Veränderung
Endet am 18.10.24

Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Raymond James from $95.00 to $85.00. They now have an "outperform" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,08 %
Kursziel 78,81
Veränderung
Endet am 26.10.24

Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $95.00 to $83.00. They now have a "buy" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for HOLX provided by MarketBeat

Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,05 %
Kursziel 83,24
Veränderung
Endet am 02.02.25

Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $83.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,74 %
Kursziel 81,44
Veränderung
Endet am 02.02.25

Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Raymond James from $85.00 to $88.00. They now have an "outperform" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,11 %
Kursziel 88,11
Veränderung
Endet am 03.04.25

Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $95.00 price target on the stock, up previously from $80.00.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,17 %
Kursziel 83,47
Veränderung
Endet am 10.04.25

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,48 %
Kursziel 83,38
Veränderung
Endet am 03.05.25

Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,50 %
Kursziel 84,52
Veränderung
Endet am 03.05.25

Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at JPMorgan Chase & Co. from $85.00 to $91.00. They now have an "overweight" rating on the stock.
Ratings data for HOLX provided by MarketBeat

Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for HOLX provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,82 %
Kursziel 88,16
Veränderung
Endet am 09.05.25

Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus from $89.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for HOLX provided by MarketBeat